Last reviewed · How we verify
Control: Zyrtec
At a glance
| Generic name | Control: Zyrtec |
|---|---|
| Sponsor | JDP Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Control: Zyrtec CI brief — competitive landscape report
- Control: Zyrtec updates RSS · CI watch RSS
- JDP Therapeutics, Inc. portfolio CI